Theramx Inc.

Creating Value for the World


2022.01.14 : Medical today - Theramx, Exports ‘EG-Q Bond’, a Topical Skin Adhesive for epidermal bonding, to Spain(Europe)
Writer 관리자 Date 2022.01.17 Hit 203
File file  file  

Theramx announced on the 14th that it has signed an annual export contract with the Madrid Regional Health Agency, Spain, and has completed the delivery of the product.

The product exported to Spain is EG-Q Bond, a bioadhesive for epidermal bonding that joins the affected area without using a separate suture for 20,000 endoscopic and laparoscopic surgeries.

A Theramx official said, “We are devoting ourselves to continuous investment and development to provide a healthy life for all mankind through our patented bioadhesive technology and the development of AI-based diagnostic devices and diagnostic platforms under development. , and is also negotiating export contracts with other European countries such as Romania. In addition, we have improved the production capacity of the manufacturing facility (GMP) to expand overseas exports and expand the domestic market.”

Meanwhile, Theramx has been certified by the Korean Ministry of Food and Drug Safety, CE certification, and international standard quality certifications such as ISO13485.